Three Novel Variants Identified in Fbn1 and Tgfbr2 in Seven Iranian Families With Suspected Marfan Syndrome Publisher Pubmed



Bitarafan F¹ ; Razmara E² ; Khodaeian M³ ; Keramatipour M⁴ ; Kalhor A⁵ ; Jafarinia E² ; Garshasbi M² Show Affiliations
Source: Molecular Genetics and Genomic Medicine Published:2020

Abstract

Background: Marfan syndrome (MFS) is a multi-systemic autosomal dominant disease of the connective tissue characterized by the early development of thoracic aneurysms/dissections, along with various manifestations of the ocular and skeletal systems. Due to the genetic and clinical heterogeneity, the clinical diagnosis of this disorder is challenging. Loss-of-function mutations in FBN1 (encodes fibrillin-1) lead to MFS type 1. Also, similar mutations in transforming growth factor β receptor 2 (TGFBR2) gene cause MFS type 2. Both proteins involve in TGF-β signaling. Methods: In this study, genetic screening using a panel involving 14 genes, especially FBN1 and TGFBR2, were performed on seven representatives affected members of seven unrelated Iranian families suspected with MFS. To confirm the variants, Sanger sequencing was applied to other affected/unaffected members of the families. Results: A total of 13 patients showed MFS manifestations. Using genetic screening, two novel and three previously reported variants in FBN1 were identified. We also detected two variants (a novel and a previously reported variant) in the TGFBR2 gene. Conclusion: In this study, we introduce three novel variants identified through gene screening in seven Iranian MFS families. This report is expected to considerably improve genetic counseling for Iranian MFS families. Early precise molecular diagnosis can be helpful for better management and improving the life expectancy of these patients. © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC